Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

25-02-19	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
25-02-16	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	2.71M 2.33M 2.19M 2M 3.74M 258M 3.75M 26M 10.05M 131M 10.17M 9.94M 416M	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	12.83M 11.04M 10.39M 9.47M 17.72M 1.22B 17.79M 123M 47.61M 622M 48.17M 47.12M 1.97B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

25-02-19	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
25-02-16	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
25-02-10	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
25-02-10	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
25-02-10	Avinger, Inc. Announces Executive Changes	CI
24-12-24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24-12-24	US Futures Tread Water Ahead of Holiday Break	MT
24-12-23	Iberdrola Completes Merger with Avangrid	MT
24-11-07	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-11-07	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
24-11-07	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
24-11-07	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
24-10-04	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

23-04-21	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
22-05-11	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
22-03-18	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
21-06-29	Avinger : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

25-01-02	Avinger : Private Placement Form 8 K	PU
24-11-07	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
24-11-07	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
24-11-07	Avinger: Q3 Earnings Snapshot	AQ
24-10-25	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

AVINGER Stock Nasdaq

Stocks

Advanced Medical Equipment & Technology

Valuation : AVINGER

Latest news : AVINGER

Analysts' recommendations : AVINGER

Press Releases : AVINGER

Managers and Directors : AVINGER

Medical Imaging Systems

Financials

Company Profile

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	2024-08-04

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-3.27%	-0.70%	-32.62%	-2.46%	12.61B
IRAY GROUP	-1.50%	-2.49%	+12.36%	+12.14%	4.22B
SONOSCAPE MEDICAL CORP.	-3.45%	+4.76%	-43.56%	-51.84%	1.29B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-2.60%	-4.81%	-42.61%	-42.00%	1.1B
IRADIMED CORPORATION	-1.00%	-3.03%	+16.23%	+77.00%	1.07B
NINGBO JANSEN SUPERCONDUCTING TECHNOLOGIES CO., LTD.	-3.14%	-7.16%	-	-	1B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	-2.61%	-5.20%	-38.22%	-	1B
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	-1.55%	+0.20%	+32.46%	+111.81%	521M
CAPSOVISION, INC.	+0.16%	+7.42%	+78.93%	-	319M
Average	-2.11%	-0.69%	-2.13%	+17.44%	2.57B
Weighted average by Cap.	-2.70%	-1.62%	-19.93%	+2.30%

	2022	2023
Net sales	8.27M 7.12M 6.7M 6.11M 11.43M 787M 11.47M 79.44M 30.7M 401M 31.07M 30.39M 1.27B	7.65M 6.58M 6.2M 5.65M 10.57M 728M 10.61M 73.48M 28.4M 371M 28.73M 28.11M 1.18B
Net income	-17.62M -15.16M -14.28M -13.01M -24.34M -1.68B -24.44M -169M -65.41M -854M -66.17M -64.74M -2.71B	-18.32M -15.76M -14.84M -13.52M -25.31M -1.74B -25.41M -176M -67.99M -888M -68.79M -67.3M -2.81B
Net Debt	1.76M 1.51M 1.42M 1.3M 2.43M 167M 2.44M 16.86M 6.52M 85.13M 6.59M 6.45M 270M	10.12M 8.71M 8.2M 7.47M 13.98M 963M 14.03M 97.18M 37.56M 491M 38M 37.17M 1.55B

End-of-day quote Nasdaq
- ^USD	-